Literature DB >> 25348851

IBD: Global variations in environmental risk factors for IBD.

Gilaad G Kaplan1.   

Abstract

Mesh:

Year:  2014        PMID: 25348851     DOI: 10.1038/nrgastro.2014.182

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

Review 1.  The global burden of IBD: from 2015 to 2025.

Authors:  Gilaad G Kaplan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

2.  Therapeutic Effects of Mesenchymal Stem Cells Derived From Bone Marrow, Umbilical Cord Blood, and Pluripotent Stem Cells in a Mouse Model of Chemically Induced Inflammatory Bowel Disease.

Authors:  Argyro Kagia; Maria Tzetis; Emmanuel Kanavakis; Despina Perrea; Irene Sfougataki; Anny Mertzanian; Ioanna Varela; Aikaterini Dimopoulou; Angeliki Karagiannidou; Evgenios Goussetis
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

3.  Janus Kinase Inhibitors for the Management of Patients With Inflammatory Bowel Disease.

Authors:  Rocio Sedano; Christopher Ma; Vipul Jairath; Brian G Feagan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2022-01

Review 4.  Overview of Three Proliferation Pathways (Wnt, Notch, and Hippo) in Intestine and Immune System and Their Role in Inflammatory Bowel Diseases (IBDs).

Authors:  Seyed Mobin Khoramjoo; Nesa Kazemifard; Shaghayegh Baradaran Ghavami; Maryam Farmani; Shabnam Shahrokh; Hamid Asadzadeh Aghdaei; Ghazal Sherkat; Mohammad Reza Zali
Journal:  Front Med (Lausanne)       Date:  2022-05-23

5.  Ulcerative Colitis Patients With Clostridium difficile are at Increased Risk of Death, Colectomy, and Postoperative Complications: A Population-Based Inception Cohort Study.

Authors:  María E Negrón; Ali Rezaie; Herman W Barkema; Kevin Rioux; Jeroen De Buck; Sylvia Checkley; Paul L Beck; Matthew Carroll; Richard N Fedorak; Levinus Dieleman; Remo Panaccione; Subrata Ghosh; Gilaad G Kaplan
Journal:  Am J Gastroenterol       Date:  2016-04-19       Impact factor: 10.864

Review 6.  Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.

Authors:  Chunhua Yang; Didier Merlin
Journal:  Int J Nanomedicine       Date:  2019-11-13

Review 7.  Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease.

Authors:  De-Feng Li; Mei-Feng Yang; Jing Xu; Hao-Ming Xu; Min-Zheng Zhu; Yu-Jie Liang; Yuan Zhang; Cheng-Mei Tian; Yu-Qiang Nie; Rui-Yue Shi; Li-Sheng Wang; Jun Yao
Journal:  Int J Nanomedicine       Date:  2022-09-05

8.  Inflammatory Bowel Disease in Asia: A Second Chance at Uncovering Environmental Factors.

Authors:  Lindsey Konkel
Journal:  Environ Health Perspect       Date:  2016-03       Impact factor: 9.031

Review 9.  ER Stress and the UPR in Shaping Intestinal Tissue Homeostasis and Immunity.

Authors:  Olivia I Coleman; Dirk Haller
Journal:  Front Immunol       Date:  2019-12-04       Impact factor: 7.561

Review 10.  Interfering With Inflammation: Heterogeneous Effects of Interferons in Graft-Versus-Host Disease of the Gastrointestinal Tract and Inflammatory Bowel Disease.

Authors:  Eileen Haring; Robert Zeiser; Petya Apostolova
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.